Biography and Research Information
OverviewAI-generated summary
Ruston M. Koonce's research at the University of Arkansas for Medical Sciences focuses on examining associations between health conditions and therapeutic interventions. His work investigates opioid therapy trajectories and their potential adverse health events, as well as the relationship between suspected long COVID and stimulant prescribing patterns in the United States. He has also contributed to research on cardiovascular outcomes in patients with type 2 diabetes initiating specific medications.
Koonce has co-authored publications with collaborators including Bradley C. Martin and Laura E. Gressler from the University of Arkansas for Medical Sciences. His scholarly output includes three publications with a total of 11 citations and an h-index of 2. His most recent publication was in 2023, indicating recent activity in his research endeavors.
Metrics
- h-index: 2
- Publications: 3
- Citations: 11
Selected Publications
-
The association between suspected long–COVID and stimulant prescribing in the United States (2023)
-
CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data (2022)
-
Association between opioid therapy trajectories and potential opioid‐related adverse health events (2022)
Collaboration Network
Top Collaborators
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- The association between suspected long–COVID and stimulant prescribing in the United States
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data
Similar Researchers
Based on overlapping research topics